Earlier this year, the Barnes-Jewish Hospital at Washington University School of Medicine in St. Louis adopted the ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
September 29, 2014 — Before undergoing cardiac imaging procedures involving radiation, healthcare providers should help ...
September 26, 2014 — In response to new science showing that complete revascularization of all significantly blocked ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
By Dave Fornell, editor of DAIC Magazine
The key take away messages from the 26th annual Transcatheter Cardiovascular ...
Doug Drachman, M.D., Mass General Hospital Institute of Heart, Vascular and Stroke Care, explains how to prevent and ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
Ziad Ali, M.D., senior scientist at the Cardiovascular Research Foundation (CRF), discusses the current trials and ...
DAIC Editor Dave Fornell offers his choices of the most innovative new cardiovascular technologies discussed in sessions ...
September 26, 2014 — The first large prospective study to examine the effectiveness of laser atherectomy in the ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
September 25, 2014 — Svelte Medical Systems reported that its drug-eluting coronary stent Integrated Delivery System ...
September 24, 2014 — A new study that compares the use of an everolimus-eluting bioresorbable vascular scaffold (BVS) ...
September 24, 2014 — Abbott announced positive one-year clinical results from ABSORB II, the world's first prospective ...